Carlos A Ordoñz1, Mansoor Khan2, Bryan Cotton3, Bruno Perreira4, Megan Brenner5, Paula Ferrada6, Tal Horer7, David Kauvar8, Andrew Kirkpatrick9,10,11, Artai Priouzram12, Derek Roberts13, Juan Duchesne14. 1. Fundación Valle del Lili, Division of Trauma and Acute Care Surgery, Department of Surgery, Universidad del Valle, Cali, Colombia. 2. Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, UK. 3. Department of Surgery, University of Texas Health Science Center, Houston, Texas. 4. Department of Surgery and Surgical Critical Care, University of Campinas, Campinas, Brazil. 5. Department of Surgery, University of California Riverside, Riverside, California. 6. VCU Surgery Trauma, Critical Care and Emergency Surgery, Richmond, Virginia. 7. Department of Cardiothoracic and Vascular Surgery, Faculty of Life Science Orebro University Hospital and University, Orebro, Sweden. 8. Vascular Surgery Service, San Antonio Military Medical Center, San Antonio, Texas. 9. Regional Trauma Services, Foothills Medical Centre, Calgary, Alberta, Canada. 10. Departments of Surgery, Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada. 11. Canadian Forces Health Services, Canada. 12. Department of Cardiothoracic and Vascular Surgery, Linkoping University Hospital, Linkoping, Sweden. 13. Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, The Ottawa Hospital, Civic Campus, Ottawa, Ontario, Canada. 14. Department of Surgery Tulane, New Orleans, Louisiana.
Abstract
PURPOSE: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is now performed in many trauma centers, it is used at more than 250 hospitals in the United States and there is an increase rate of publications with the experience in these centers, but there is a gap of knowledge regarding the use of REBOA in Latin-America. This paper endeavors to describe the utilization of REBOA at a high level Latin-American Trauma Center and the transition from a large caliber to a low-profile device with the concomitant reduction in the groin access complications. METHODS: A prospective, observational, single-center study was conducted. We included all trauma patients who underwent REBOA. We recorded data from admission parameters, complications, and clinical outcomes. RESULTS: Fifty patients were included. Most of the REBOA catheters were inserted in the operating room [47 (94%)], and the arterial access was done by surgical cutdown [40 (80%)]. All the complications were associated with the catheter of 11 Fr Sheath used in 36 patients [n = 8/36 (22%) vs. n = 0/14 (0%); P = 0.05]. CONCLUSION: REBOA can be used safely in blunt or penetrating thoracic, abdominal, and pelvic trauma. The insertion of a 7 Fr Sheath was associated with lower complications, so its use should be preferred over larger calibers.
PURPOSE: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is now performed in many trauma centers, it is used at more than 250 hospitals in the United States and there is an increase rate of publications with the experience in these centers, but there is a gap of knowledge regarding the use of REBOA in Latin-America. This paper endeavors to describe the utilization of REBOA at a high level Latin-American Trauma Center and the transition from a large caliber to a low-profile device with the concomitant reduction in the groin access complications. METHODS: A prospective, observational, single-center study was conducted. We included all trauma patients who underwent REBOA. We recorded data from admission parameters, complications, and clinical outcomes. RESULTS: Fifty patients were included. Most of the REBOA catheters were inserted in the operating room [47 (94%)], and the arterial access was done by surgical cutdown [40 (80%)]. All the complications were associated with the catheter of 11 Fr Sheath used in 36 patients [n = 8/36 (22%) vs. n = 0/14 (0%); P = 0.05]. CONCLUSION: REBOA can be used safely in blunt or penetrating thoracic, abdominal, and pelvic trauma. The insertion of a 7 Fr Sheath was associated with lower complications, so its use should be preferred over larger calibers.
Authors: Carlos A Ordoñez; Michael W Parra; Yaset Caicedo; Natalia Padilla; Fernando Rodríguez-Holguín; José Julián Serna; Alexander Salcedo; Alberto García; Claudia Orlas; Luis Fernando Pino; Ana Milena Del Valle; David Mejia; Juan Carlos Salamea-Molina; Megan Brenner; Tal Hörer Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Carlos A Ordoñez; Michael W Parra; José Julián Serna; Fernando Rodríguez-Holguin; Alberto García; Alexander Salcedo; Yaset Caicedo; Natalia Padilla; Luis Fernando Pino; Adolfo González Hadad; Mario Alain Herrera; Mauricio Millán; Laureano Quintero-Barrera; Fabian Hernández-Medina; Ricardo Ferrada; Megan Brenner; Todd Rasmussen; Thomas Scalea; Rao Ivatury; John B Holcomb Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Carlos A Ordoñez; Michael W Parra; Mauricio Millán; Yaset Caicedo; Mónica Guzmán-Rodríguez; Natalia Padilla; Juan Carlos Salamea-Molina; Alberto García; Adolfo González-Hadad; Luis Fernando Pino; Mario Alain Herrera; Fernando Rodríguez-Holguín; José Julián Serna; Alexander Salcedo; Gonzalo Aristizábal; Claudia Orlas; Ricardo Ferrada; Thomas Scalea; Rao Ivatury Journal: Colomb Med (Cali) Date: 2020-12-30
Authors: Yaset Caicedo; Linda M Gallego; Hugo Jc Clavijo; Natalia Padilla-Londoño; Cindy-Natalia Gallego; Isabella Caicedo-Holguín; Mónica Guzmán-Rodríguez; Juan J Meléndez-Lugo; Alberto F García; Alexander E Salcedo; Michael W Parra; Fernando Rodríguez-Holguín; Carlos A Ordoñez Journal: Eur J Med Res Date: 2022-10-17 Impact factor: 4.981
Authors: Ramiro Manzano-Nunez; David McGreevy; Claudia P Orlas; Alberto F García; Tal M Hörer; Joseph DuBose; Carlos A Ordoñez Journal: World J Emerg Surg Date: 2020-10-12 Impact factor: 5.469